David J Mazur-Hart, Brannan E O'Neill, Brandi W Pang, Melanie H Hakar, Matthew D Wood, Sachin Gupta, Christina M Sayama, Jesse J Liu, Aclan Dogan
{"title":"Operative Technique: Angiomatoid Fibrous Histiocytoma-Unique Case and Management.","authors":"David J Mazur-Hart, Brannan E O'Neill, Brandi W Pang, Melanie H Hakar, Matthew D Wood, Sachin Gupta, Christina M Sayama, Jesse J Liu, Aclan Dogan","doi":"10.1055/s-0042-1754320","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objective</b> We describe the first jugular foramen angiomatoid fibrous histiocytoma (AFH) case and the first treatment with preoperative endovascular embolization. AFH is a rare intracranial neoplasm, primarily found in pediatric patient extremities. With an increase in AFH awareness and a well-described genetic profile, intracranial prevalence has also subsequently increased. <b>Study Design</b> We compare this case to previously reported cases using PubMed/Medline literature search, which was performed using the algorithm [\"intracranial\" AND \"angiomatoid fibrous histiocytoma\"] through December 2020 (23 manuscripts with 46 unique cases). <b>Patient</b> An 8-year-old female presented with failure to thrive and right-sided hearing loss. Work-up revealed an absence of right-sided serviceable hearing and a large jugular foramen mass. Angiogram revealed primary arterial supply from the posterior branch of the ascending pharyngeal artery, which was preoperatively embolized. <b>Intervention</b> Gross total resection was performed via a translabyrinthine approach. <b>Conclusion</b> The case presented is unique; the first reported AFH at the jugular foramen and the first reported case utilizing preoperative embolization. Preoperative embolization is a relatively safe technique that can improve the surgeon's ability to perform a maximally safe resection, which may decrease the need for adjuvant radiation in rare skull base tumors in young patients.</p>","PeriodicalId":44256,"journal":{"name":"Journal of Neurological Surgery Reports","volume":" ","pages":"e110-e118"},"PeriodicalIF":0.6000,"publicationDate":"2022-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e5/9a/10-1055-s-0042-1754320.PMC9489471.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Neurological Surgery Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0042-1754320","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/7/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective We describe the first jugular foramen angiomatoid fibrous histiocytoma (AFH) case and the first treatment with preoperative endovascular embolization. AFH is a rare intracranial neoplasm, primarily found in pediatric patient extremities. With an increase in AFH awareness and a well-described genetic profile, intracranial prevalence has also subsequently increased. Study Design We compare this case to previously reported cases using PubMed/Medline literature search, which was performed using the algorithm ["intracranial" AND "angiomatoid fibrous histiocytoma"] through December 2020 (23 manuscripts with 46 unique cases). Patient An 8-year-old female presented with failure to thrive and right-sided hearing loss. Work-up revealed an absence of right-sided serviceable hearing and a large jugular foramen mass. Angiogram revealed primary arterial supply from the posterior branch of the ascending pharyngeal artery, which was preoperatively embolized. Intervention Gross total resection was performed via a translabyrinthine approach. Conclusion The case presented is unique; the first reported AFH at the jugular foramen and the first reported case utilizing preoperative embolization. Preoperative embolization is a relatively safe technique that can improve the surgeon's ability to perform a maximally safe resection, which may decrease the need for adjuvant radiation in rare skull base tumors in young patients.